Evaluating the Therapeutic Effect of Scalp Acupuncture Treatment for Motor Dysfunction in Children With Cerebral Palsy

• ClinicalTrials.gov Identifier: NCT03921281
• Recruitment Status: Recruiting
• First Posted: April 19, 2019
• Last Update Posted: May 6, 2020
• Sponsor: Children's Hospital of Fudan University
• Information provided by (Responsible Party): Children's Hospital of Fudan University

Study Description

Brief Summary:

The investigators design a Multi-center randomized, control study to evaluate the therapeutic effect of the scalp acupuncture treatment for motor dysfunction in children with cerebral palsy by using the following outcomes: motor function, activity of daily living, quality of life.

Condition or disease	Intervention/treatment	Phase
Cerebral Palsy; Motor Dysfunction; Acupuncture	Other: scalp acupuncture treatment; Other: Rehabilitation Treatment	Not Applicable

Detailed Description:

Cerebral palsy (CP) is a well-recognized neurodevelopmental condition beginning in early childhood and persisting throughout the lifetime. Motor disorders are often accompanied by disturbances of sensation, cognition, communication, perception, behavior, and seizures The activities of daily living and social participation are limited in children with CP due to motor dysfunction, this greatly influences the CP patient's quality of life, and return to society.

Western conventional treatment of CP is multi-professional rehabilitation. In China, CP rehabilitation mainly develops the clinical mode of combining traditional Chinese medicine and western medicine. Acupuncture use as a complementary or alternative therapy has increased worldwide and has become widely applied to CP rehabilitation, which confirms that the efficacy of acupuncture can have a great impact on CP management. Many studies have shown that scalp acupuncture has a remarkable treatment efficacy on motor dysfunction in children with CP in China. But, Although acupuncture as a treatment for cp has become widely accepted and showed better clinical curative effect than conventional treatments, a Meta-Analysis published in 2018 based on clinical randomized controlled trials summarized that the clinical curative effect of acupuncture treatment in children with CP remains uncertain due to the small number of randomized controlled trials available and the small sample sizes. More high-quality and large-scale studies are still needed. The purpose of this study is to observe the therapeutic effect of scalp acupuncture treatment for motor dysfunction in children with CP by using the international general evaluation scales.

In this 12-week, assessor-blind, randomized, controlled study of scalp acupuncture as additional treatment with the rehabilitation treatment, a total of 76 children with cerebral palsy will be recruited. The patients will be randomly assigned to two different groups: 1) the treatment group and 2) the control group. The treatment group (n=38) will receive scalp acupuncture combined with rehabilitation treatment for 3 times per week for 12 weeks, and the control group (n=38) will receive rehabilitation treatment for 3 times per week for 12 weeks. Both groups will be evaluated at baseline, week4 (treatment 12), week 8 (treatment 24), week12(treatment 36) and week 24(follow-up) using GMFM scale, FMFM scale, PEDI scale and CP-QOL scale. The study will be conducted at Children's Hospital of Fudan University.

Study Design

• Study Type: Interventional (Clinical Trial)
• Estimated Enrollment: 76 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Double (Investigator, Outcomes Assessor)
• Primary Purpose: Treatment
• Official Title: Scalp Acupuncture Treatment for Motor Dysfunction in Children With Cerebral Palsy: Study Protocol for a Randomized Controlled Trial
• Actual Study Start Date: December 1, 2018
• Estimated Primary Completion Date: December 31, 2020
• Estimated Study Completion Date: December 31, 2020

Arms and Interventions

Arm	Intervention/treatment
Experimental: treatment group; The treatment group (n=38) will receive scalp acupuncture combined with rehabilitation treatment for 3 times per week for 12 weeks.	Other: scalp acupuncture treatment; The parameters for scalp acupuncture are set as follows: Scalp acupoint selection: The Motor Area of Jiao's Scalp acupuncture and Si shencong (EX-HN1).; Acupuncture manipulation: Disposable stainless steel needles will be manually inserted in at an approximately 15-degree angle to a depth of 1.5-2.0 cm respectively along the upper point and middle point of the motor area on the scalp. The acupuncture direction of Si shencong (EX-HN1) acupoint is toward the Baihui (GV20) acupoint. the needles will be rotated for at least 200 revolutions per minute for 1 minute every 20 minutes for a total of 60 minutes.; Treatment course: three times a week, 12 weeks in total.; Other: Rehabilitation Treatment; The children with CP will receive the conventional rehabilitation programs as mentioned above. The rehabilitation programs will be carried out three times a week (once every other day) for 12 weeks, and every time, the rehabilitation treatment (PT and OT) will last approximately for 1 hour. All rehabilitation treatments will be carried out by qualified therapists.
control group; The control group (n=38) will receive rehabilitation treatment for 3 times per week for 12 weeks.	Other: Rehabilitation Treatment; The children with CP will receive the conventional rehabilitation programs as mentioned above. The rehabilitation programs will be carried out three times a week (once every other day) for 12 weeks, and every time, the rehabilitation treatment (PT and OT) will last approximately for 1 hour. All rehabilitation treatments will be carried out by qualified therapists.

Outcome Measures

Primary Outcome Measures :

1. Change from Baseline GMFM at 4 weeks, 8 weeks and 12 weeks [ Time Frame: The GMFM will be assessed at baseline, interventions period (4 weeks, 8 weeks and 12 weeks) and fellow-up period at (24 weeks). ]
   The Gross Motor Function Measure (GMFM) is a standardized observational instrument designed to assess the gross motor function of children with CP. It is divided into five sections: Lying and Rolling, Sitting, Crawling and Kneeling, Standing, and Walking, Running and Jumping. Each item is on the basis of four levels: 0=does not initiate, 1=initiates, 2=partially completes, 3=completes or NT=not tested. The total score is a summation of the scores in the five areas by the Gross Motor Ability Estimator software (GMAE Version 1.0.)
2. Change from Baseline FMFM at 4 weeks, 8 weeks and 12 weeks [ Time Frame: The FMFM will be assessed at baseline, interventions period (4 weeks, 8 weeks and 12 weeks) and fellow-up period at (24 weeks). ]
   The Fine Motor Function Measure (FMFM) assessment scale is used to evaluate the fine motor activities of children with CP, including the upper limb activities and sensory ability. This scale includes five domains, namely audiovisual tracking ability(5 items), upper limb joint's ability(9 items), grasping ability(10 items), operation ability(13 items)and hand-eye coordination(24 items). Each item is on the basis of four levels: 0=does not initiate, 1=initiates, 2=partially completes, 3=completes. The total score(0～100 points) is a summation of the scores in the five areas.

Secondary Outcome Measures :

1. Change from Baseline PEDI at 4 weeks, 8 weeks and 12 weeks [ Time Frame: PEDI will be assessed at baseline, interventions period (4 weeks, 8 weeks and 12 weeks) and fellow-up period at (24 weeks). ]
   Pediatric Evaluation of Disability Inventory (PEDI) measures both functional performance and capability within three domains of (1) self-care, (2) mobility, and (3) social function in two categories, that is, the Functional Skills Scale (FSS), Caregiver Assistance Scale (CAS), and Modifications Scale. FSS covers 40 diverse content areas assessed using 197 items scored unable (0) or capable (1). The self-care domain comprises 73 items. The mobility domain has 59 items. The social function domain has 65 items. CAS It covers 20 diverse content areas assessed using 20 items scored on the following escalating 6-point scale: independent, supervision, minimal help, moderate help, maximum help, and total help. The items cover the self-care domain (n = 8), mobility domain (n = 7), and social function domain (n = 5). Modifications Scale measures any environmental or technical modifications needed to enhance the child's function.
2. Change from Baseline CPQOL at 4 weeks, 8 weeks and 12 weeks [ Time Frame: CPQOL will be assessed at baseline, interventions period (4 weeks, 8 weeks and 12 weeks) and fellow-up period at (24 weeks). ]
   The cerebral palsy quality of life questionnaire for children contains 66 items in seven domains: Social well-being and acceptance (SWB), Functioning (FUN), Participation and physical health (PART), Emotional well-being (EWB), Access to services (ACCESS), Pain and feeling about disability (PAIN), and Family health (FAMILY). Almost all of the items have the following item stem: 'How do you think your child feels about. . .' and a 9-point rating scale, where 1 = very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.

Eligibility Criteria

• Ages Eligible for Study: 12 Months to 72 Months (Child)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

1. cerebral palsy patients between 12 and 72 months old
2. cerebral palsy was diagnosed according to the criteria of CP in international guidelines
3. children with CP of the spastic type
4. voluntary participation and informed consent signed

Exclusion Criteria:

1. visual, auditory and mental disorders, affecting the rehabilitation assessment
2. the child with epilepsy who is not under control with medication
3. bleeding tendencies
4. being oversensitive to acupuncture
5. use of muscle relaxants or herbal therapies during the study period
6. participation in another clinical trial

Contacts and Locations

Contacts

Contact: Hong Yang, Ph.D.; 86-021-54934001 ext 8310; hyang@shmu.edu.cn

Contact: Wei Shi, B.D.; 86-021-54934001 ext 8310; shiweixiyi@163.com

Locations

China, Shanghai

Children's Hospital of Fudan University; Recruiting

Shanghai, Shanghai, China, 201102

Contact: Jun Wang, MD 86-021-54934001 ext 8310 13512183795@163.com

Contact: Hong Yang, MD 86-021-54934001 ext 8310 hyang@shmu.edu.cn

Principal Investigator: Jun Wang, Ph.D.

Sub-Investigator: Sujuan Wang, Ph.D.

Sub-Investigator: Xiaojuan Shi, B.D.

Sub-Investigator: Dandan Luo, B.D.

Sub-Investigator: Bingpei Shi, B.D.

Sub-Investigator: Kai Lu, B.D.

Sub-Investigator: Chun Zhai, B.D.

Sub-Investigator: Yelin Yao, M.D.

Sponsors and Collaborators

Children's Hospital of Fudan University

Investigators

• Principal Investigator: Jun Wang, Ph.D.; Children's Hospital of Fudan University

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Wang J, Shi W, Khiati D, Shi B, Shi X, Luo D, Wang Y, Deng R, Huang H, Li J, Yan W, Yang H. Acupuncture treatment on the motor area of the scalp for motor dysfunction in children with cerebral palsy: study protocol for a multicenter randomized controlled trial. Trials. 2020 Jan 6;21(1):29. doi: 10.1186/s13063-019-3986-z.

• Responsible Party: Children's Hospital of Fudan University
• ClinicalTrials.gov Identifier: NCT03921281
• Other Study ID Numbers: CHFudanU-1
• First Posted: April 19, 2019
• Last Update Posted: May 6, 2020
• Last Verified: May 2020

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: No
• Plan Description: Because our data is managed by the clinical trial unit. We will respect the opinions of the clinical research unit management committee and the subjects, which will ultimately decide whether to share the study data with other researchers.

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Children's Hospital of Fudan University:

Cerebral palsy; Motor dysfunction; Scalp acupuncture treatment; Safety/Efficacy assessment

Additional relevant MeSH terms:

Paralysis; Cerebral Palsy; Neurologic Manifestations; Nervous System Diseases; Brain Damage, Chronic; Brain Diseases; Central Nervous System Diseases